175 related articles for article (PubMed ID: 8364189)
1. CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia.
Hirayama Y; Kohgo Y; Kanisawa Y; Fujii S; Ikeda K; Matsunaga T; Ito Y; Sakamaki S; Niitsu Y
Int J Hematol; 1993 Jun; 57(3):265-8. PubMed ID: 8364189
[TBL] [Abstract][Full Text] [Related]
2. [Blast crisis of chronic myelogenous leukemia with blasts expressing both immature B lymphocyte- and myelomonocyte-associated antigens and differentiating into basophils in vitro].
Utsunomiya Y; Iwamasa K; Yasukawa M; Tamai T; Shiosaka T; Bando S
Rinsho Ketsueki; 1990 Jul; 31(7):1017-21. PubMed ID: 2214182
[TBL] [Abstract][Full Text] [Related]
3. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
4. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
5. Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor.
Murase T; Suzuki R; Tashiro K; Morishima Y; Nakamura S
Int J Hematol; 1999 Feb; 69(2):89-91. PubMed ID: 10071456
[TBL] [Abstract][Full Text] [Related]
6. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies.
Robak T
Arch Immunol Ther Exp (Warsz); 1988; 36(4):471-85. PubMed ID: 3074744
[TBL] [Abstract][Full Text] [Related]
7. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
Schmetzer HM; Gerhartz HH
Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia.
López-Karpovitch X; Cárdenas R; Piedras J
Rev Invest Clin; 1997; 49(1):31-6. PubMed ID: 9229753
[TBL] [Abstract][Full Text] [Related]
9. [Undifferentiated blastic cell crisis of chronic myelogenous leukemia with myeloblastic tumor in the skin].
Kawakami K; Kiyosaki M; Amaya H; Nakamaki T; Hino K; Tomoyasu S
Rinsho Ketsueki; 2000 Apr; 41(4):334-40. PubMed ID: 10846465
[TBL] [Abstract][Full Text] [Related]
10. [Immunophenotype of blast crisis in chronic myeloid leukemia].
Favre G; Passweg J; Hoffmann T; Speck B; Gratwohl A; Tichelli A
Schweiz Med Wochenschr; 1998 Oct; 128(42):1624-6. PubMed ID: 9824896
[TBL] [Abstract][Full Text] [Related]
11. [A "primitive" variant of the blast crisis in chronic myeloleukemia].
Baryshnikov AIu; Turkina AG; Moiseenkova IN; Frolova EA; Sediakhina NP; Diagileva OA; Khoroshko ND; Mokeeva RA
Ter Arkh; 1995; 67(7):22-5. PubMed ID: 7482298
[TBL] [Abstract][Full Text] [Related]
12. The onset of CML in blastic crisis: molecular features.
Gregorini A; Filippetti A; Luchetti F; Walker A; Lillington DM; Papa S; Valentini M
J Biol Regul Homeost Agents; 1997; 11(3):111-4. PubMed ID: 9498160
[TBL] [Abstract][Full Text] [Related]
13. Extramedullary pleural blast crisis in chronic myelogenous leukemia: cytogenetic and molecular study.
Sacchi S; Temperani P; Selleri L; Zucchini P; Morselli S; Vecchi A; Longo R; Torelli G; Emilia G; Torelli U
Acta Haematol; 1990; 83(4):198-202. PubMed ID: 2115717
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival.
Urbano-Ispizua A; Cervantes F; Matutes E; Villamor N; Pujades A; Sierra J; Feliu E; Vives-Corrons JL; Montserrat E; Rozman C
Leukemia; 1993 Sep; 7(9):1349-54. PubMed ID: 8371586
[TBL] [Abstract][Full Text] [Related]
15. Acute bilineage leukemia after chronic myelogenous leukemia.
Williams SR; Wellhausen SR; Barker RL; Janckila AJ
J Ky Med Assoc; 1997 Sep; 95(9):393-6. PubMed ID: 9322413
[TBL] [Abstract][Full Text] [Related]
16. Potent antileukemic activity of the novel agents norsegoline and dibezine.
Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals.
Kharfan-Dabaja M; Ayala E; Lindner I; Cejas PJ; Bahlis NJ; Kolonias D; Carlson LM; Lee KP
Cancer Immunol Immunother; 2005 Jan; 54(1):25-36. PubMed ID: 15693136
[TBL] [Abstract][Full Text] [Related]
18. Role of immunophenotyping in characterisation of blast crisis of chronic myeloid leukemia--a study of 25 cases.
Padmanabhan V; Varma N; Dash S; Varma S
Indian J Pathol Microbiol; 1996 Jan; 39(1):13-7. PubMed ID: 8755126
[TBL] [Abstract][Full Text] [Related]
19. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
[TBL] [Abstract][Full Text] [Related]
20. Predictors for prognosis of chronic myelocytic leukemia.
Chen SS; Zhang HF; Xue WT; Li K; Wang P; Lui Y
Chin Med J (Engl); 1993 Oct; 106(10):760-2. PubMed ID: 7913433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
